Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00059839 · ClinicalTrials.gov registry record · Phase 3
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
A Phase 3 study, sponsored by Children's Oncology Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 129
- Enrollment target
NCT00059839 is a Phase 3 study that has completed, run by Children's Oncology Group. The registered enrollment target is 129 participants.
The verdict
NCT00059839, a Phase 3 study, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 129 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. It is not yet known if combination chemotherapy with vinblastine is more effective than combination chemotherapy with vincristine in treating advanced anaplastic large cell lymphoma. PURPOSE: Randomized phase III trial to compare the effectiveness of two combination chemotherapy regimens with either vinblastine or vincristine in treating patients who have newly diagnosed advanced anaplastic large cell lymphoma.
Interventions
- DRUG prednisone
- DRUG mercaptopurine
- DRUG methotrexate
- DRUG doxorubicin hydrochloride
- DRUG vinblastine sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2003-11 |
| Est. Completion | 2014-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00059839
The ClinicalTrials.gov registry entry for NCT00059839 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which prednisone is the first listed.
NCT00059839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00059839 about?
NCT00059839 is a clinical study titled "Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma". RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. It is not yet known if combination chemotherapy with vinblastine is more effective than combination chemotherapy with vinc...
What is the current status of trial NCT00059839?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 129 participants. The study started on 2003-11. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00059839?
The interventions under investigation include: prednisone (DRUG), mercaptopurine (DRUG), methotrexate (DRUG), doxorubicin hydrochloride (DRUG), vinblastine sulfate (DRUG).
Who is sponsoring clinical trial NCT00059839?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.